Transcatheter Mitral Valve Replacement Market

TMVR, also known as transcatheter mitral valve replacement is a way of replacing the mitral valve in the heart without the need for conventional open-heart surgery. TMVR transcatheter mitral valve replacement is a treatment for mitral valve stenosis (tight mitral valve) or mitral valve regurgitation (leaky mitral valve) or a mix of the two. TMVR transcatheter mitral valve replacement was developed initially as a method of replacing the mitral valve in patients considered too high risk for surgery but will likely replace mitral valve replacement surgery in the future as the technology improves and the outcomes are proved.

Transcatheter Mitral Valve Replacement Market contains market size and forecasts of Transcatheter Mitral Valve Replacement (TMVR) in Global, including the following market information:

Global Transcatheter Mitral Valve Replacement (TMVR) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Transcatheter Mitral Valve Replacement (TMVR) market was valued at 1191 million in 2021 and is projected to reach US$ 6176.8 million by 2028, at a CAGR of 26.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

MitraClip Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transcatheter Mitral Valve Replacement (TMVR) include Abbott, Edwards Lifesciences, Medtronic, Boston Scientific, Micro Interventional Devices, Neovasc, LivaNova and HighLife SAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Transcatheter Mitral Valve Replacement (TMVR) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transcatheter Mitral Valve Replacement (TMVR) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Transcatheter Mitral Valve Replacement (TMVR) Market Segment Percentages, by Type, 2021 (%)

MitraClip

Edwards PASCAL

Edwards SAPIEN 3

Global Transcatheter Mitral Valve Replacement (TMVR) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Transcatheter Mitral Valve Replacement (TMVR) Market Segment Percentages, by Application, 2021 (%)

Functional Mitral Regurgitation (FMR)

Degenerative Mitral Regurgitation (DMR)

Global Transcatheter Mitral Valve Replacement (TMVR) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Transcatheter Mitral Valve Replacement (TMVR) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Transcatheter Mitral Valve Replacement (TMVR) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Transcatheter Mitral Valve Replacement (TMVR) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

Edwards Lifesciences

Medtronic

Boston Scientific

Micro Interventional Devices

Neovasc

LivaNova

HighLife SAS